The promise of ESCAT: a new system for evaluating cancer drug–target pairs
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/s41571-018-0110-3
Abstract: The ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) will be useful as a common language to harmonize discussions in precision oncology and could also guide policy and reimbursement decisions, but it is far… read more here.
Keywords: escat new; system evaluating; evaluating cancer; new system ... See more keywords
Evaluating Cancer-Related Biomarkers Based on Pathological Images: A Systematic Review
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.763527
Abstract: Many diseases are accompanied by changes in certain biochemical indicators called biomarkers in cells or tissues. A variety of biomarkers, including proteins, nucleic acids, antibodies, and peptides, have been identified. Tumor biomarkers have been widely… read more here.
Keywords: tumor; tumor biomarkers; image; pathological images ... See more keywords